Effect of camel milk on blood glucose, cholesterol and total proteins variationsin alloxan-induced diabetic dogs

Abstract

The efficacy of camel milk on alloxan-induced diabetic dogs was evaluated in this study. Firstly, two diabetic groups ofdogs received raw camel milk (group1) or raw cow milk (group 2). One healthy group was used as control in which dogsreceived raw camel milk. Five hundred ml of raw milk were given to the animals daily for five weeks. By the end of the firsttest, group1 showed a statistically significant decline in blood glucose (from 10.88±0.55 mmol/l to 5.77±0.44 mmol/l);cholesterol (from 5.99±0.15 mmol/l to 4.4±0.62 mmol/l) and in total proteins concentrations (from 80.06 ± 2.11 g/l to 63.56 ±3.16 g/l). In this period, group 2 showed high blood glucose (8 mmol/l), cholesterol (from 5.99±0.58 to 7.13±1.25 mmol/l)and total proteins concentrations (from 79.18±6.07 to 84.33±0.56 g/l). This diabetic state was confirmed by Intraperitonealglucose tolerance test. These dogs (group 2) were treated, in test 2, with camel milk instead of bovine milk and showed animprovement in blood glucose (from 9.83±0.72 mmol/l before drinking milk to 7.83±0.88 mmol/l in week 4), proteins andlipids profiles. Dogs from group1, which were used to follow the effect of camel milk by the end of experiment, showedhealthy state: normal blood glucose levels (5.16–6.5mmol/l), cholesterol (4.14-5.51mmol/l), triglycerides(0.51-1.21mmol/l)and total proteins concentrations (60.77– 69.18 g/l). It is obvious in this study that camel milk has a therapeutic effect onalloxan-induced diabetic dogs.